Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neyt M et al. - The model shows better cost-effectiveness for the 9-week initial treatment (FinHer) compared to no trastuzumab treatment than for the 1-year post-chemotherapy treatment (HERA). Both from a medical and an economic point of view, the 9-week initial treatment regimen with trastuzumab shows promising results and justifies the initiation of a large comparative trial with a 1-year regimen.


Related Articles

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09    Relevance Score: 74%

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
British Journal of Cancer, 11/30/09    Relevance Score: 72%

Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09    Relevance Score: 72%

Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09    Relevance Score: 71%

Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09    Relevance Score: 71%

Today in Chemotherapy/Oncology...keeping you current

Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced chemo-fog
Journal of Clinical Pharmacy and Therapeutics, 03/11/10

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Cancer Letters, 03/10/10

Role of Basic Residues Within or Near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein in Drug Transport
Journal of Pharmacology and Experimental Therapeutics, 03/10/10

Today in Pharmacoeconomics...keeping you current

Cost-Effectiveness Analysis of Short-Term Clopidogrel Therapy for ST Elevation Myocardial Infarction
Critical Pathways in Cardiology, 03/11/10

Estimating the Cost of Health Care-Associated Infections: Mind Your p's and q's
Clinical Infectious Diseases, 03/08/10

Costs of Gastrointestinal Events After Outpatient Opioid Treatment for Non-Cancer Pain
Annals of Pharmacotherapy, 03/03/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address